Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment

AIDS. 2002 Mar 29;16(5):793-6. doi: 10.1097/00002030-200203290-00017.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Cohort Studies
  • Drug Resistance, Viral / genetics*
  • Female
  • France
  • Genotype
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV Protease / genetics*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects
  • HIV-1 / genetics*
  • Humans
  • Lamivudine / therapeutic use
  • Male
  • RNA, Viral
  • Ritonavir / therapeutic use
  • Viral Load
  • Zidovudine / therapeutic use

Substances

  • RNA, Viral
  • Lamivudine
  • Zidovudine
  • HIV Reverse Transcriptase
  • HIV Protease
  • Ritonavir